Nasdaq GlobeNewswire

Euro Manganese Inc. Admitted to the Frankfurt Stock Exchange, Appoints European and Australian Communications Advisors

Del

VANCOUVER, British Columbia, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Euro Manganese Inc. (TSX-V/ASX: EMN) (“EMN” or the "Company") is pleased to announce its listing on the Frankfurt Stock Exchange and the appointment of both European and Australian investor relations advisors.

In response to growing interest from European investors and due to the strategic location of EMN’s Chvaletice Manganese Project (the “Project”) in the Czech Republic, the Company has appointed Deutsche Gesellschaft für Wertpapieranalyse GmbH (“DGWA”) as its investor relations advisor in Europe. European investors can trade the Company’s common shares under the stock code “E06” on the Frankfurt Stock Exchange. Concurrently, due to the significant holdings in EMN by Australian investors and its listing on the Australian Securities Exchange, the Company has appointed NWR Communications Pty Ltd. (“NWR”) as its investor relations advisor in Australia. Both firms provide numerous investor relations services for publicly traded companies, including assisting in disseminating press releases, assisting in increasing investor awareness amongst the retail and institutional investment community, and assisting in overall marketing of the Company. The appointment of each of DGWA and NWR are subject to TSX Venture Exchange approval.

DGWA will provide investor relations services for an initial period of twelve months, which can be extended by a further twelve months upon mutual agreement by the parties, and can be cancelled by either party at the end of each six month period upon thirty days' prior notice. DGWA will be paid a fee of €7,500 per month. NWR will be paid a monthly fee of AUD$10,000 for the first two months, and a retainer of AUD$7,000 per month thereafter, with one months’ prior written notice to be provided in the event the services are to be terminated by the Company. Both DGWA and NWR will be reimbursed for all pre-approved expenses. Neither DGWA nor NWR are current shareholders of the Company.

About Deutsche Gesellschaft für Wertpapieranalyse GmbH

DGWA, is a German institute for asset management and a boutique European investment and financial markets consulting firm based in Frankfurt and Berlin, Germany. The management team has a 25-year track record in trading, investing and analyzing small and medium enterprises around the world. DGWA’s team has been involved in over 250 IPOs, financings, bond issues, dual listings and corporate finance transactions as well as corresponding road shows and awareness campaigns.

About NWR Communications Pty Ltd.

NWR is an established investor and media relations firm specialising in small to mid-cap ASX-listed companies. Their focus is on delivering strategic, effective investor and media relations campaigns designed to build companies’ profiles while reducing management time dedicated to investor issues.  Their experienced team is comprised of former journalists, stockbrokers and media relations professionals.

About Euro Manganese Inc.

Euro Manganese Inc. is a Canadian mineral resource company, whose principal focus is advancing the evaluation and development of the Chvaletice Manganese Project in which it holds a 100% interest. The Project entails re-processing a significant manganese deposit hosted in historic mine tailings, strategically-located in the Czech Republic. The Company's goal is to become a leading, competitive and environmentally superior supplier of ultra-high-purity manganese products, serving the lithium-ion battery industry, as well as producers of specialty steel and aluminum alloys.

FORWARD-LOOKING STATEMENTS:

This release may contain forward-looking statements or information. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual outcome, results, performance, or achievements of the Company to be materially different from any future outcome, results, performance, or achievements expressed or implied by the forward-looking statements. Forward looking statements or information relate to, among other things, the continued evaluation and development of the Project and the appointment of DGWA and NWR. These forward-looking statements are based on management’s current expectations and beliefs, but given the uncertainties, assumptions and risks, readers are cautioned not to place undue reliance on such forward-looking statements or information. The Company disclaims any obligation to update, or to publicly announce, any such statements, events or developments except as required by law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact:

Mr. Marco A. Romero,
President & CEO
(604)-681-1010 ext. 101
info@mn25.ca 
Website: www.mn25.ca

NWR Communications,
Ms. Karen Oswald,
m: +61 (0) 423 602 353
karen@nwrcommunications.com.au

Website: www.nwrcommunications.com.au

DGWA
Mr. Stefan Müller
+49 69 247471047
sm@dgwa.org
Website: www.DGWA.org

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

WillScot Announces Closing of Warrant Exchange Offer11.12.2018 22:05Pressemelding

BALTIMORE, Dec. 11, 2018 (GLOBE NEWSWIRE) -- WillScot Corporation (“WillScot”) (NASDAQ: WSC), the specialty rental services market leader providing innovative modular space and portable storage solutions across North America, today announced the closing of its previously announced exchange offer (the “Exchange Offer”) relating to certain outstanding warrants issued in 2015 (the “Warrants”). Under the terms of the Exchange Offer, each Warrant holder had the opportunity to receive 0.18182 shares of WillScot Class A Common Stock, par value $0.0001 per share (“Common Stock”), for each Warrant tendered by the holder and exchanged pursuant to the Exchange Offer. As of the closing of the Exchange Offer on December 11, 2018, 45,131,827 outstanding Warrants were properly tendered and not withdrawn in the Exchange Offer. 45,031,827 of the Warrants tendered were public warrants, representing approximately 89% of the public warrants, and approximately 100,000 Warrants tendered were private warrant

DoubleVerify and InMobi Unite to Combat Mobile App Fraud11.12.2018 18:02Pressemelding

Partnership brings mobile app fraud prevention to advertisers globally NEW YORK, Dec. 11, 2018 (GLOBE NEWSWIRE) -- DoubleVerify ("DV"), the leading independent provider of marketing measurement software and analytics, today announced a partnership with InMobi, a global provider of enterprise platforms for marketers. As part of the partnership, DoubleVerify will provide always-on fraud filtering and measurement for mobile in-app advertising campaigns across the InMobi Exchange globally. The integration with InMobi covers pre-bid targeting for all InMobi Exchange impressions within the leading mobile in-app platform, as well as monitoring of post-bid fraud activity, such as spoofing – enabling InMobi to continuously refine the quality of its mobile ad inventory. “DV’s partnership with InMobi demonstrates our commitment to provide consistent, comprehensive quality coverage for global brand advertisers,” said Matt McLaughlin, COO at DoubleVerify. “With ad spend increasingly concentrated in

Claroty Announces Major Enhancements to Market-Leading Industrial Cybersecurity Platform11.12.2018 15:00Pressemelding

Groundbreaking multispectral data acquisition and network segmentation capabilities provide deeper OT network visibility and reduce risk for industrial enterprises and critical infrastructure providers NEW YORK, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Claroty, the leader in operational technology (OT) network protection, today announced several significant enhancements to its award-winning Continuous Threat Detection product and technology integrations with several leading industrial automation, network infrastructure and cybersecurity providers. Already the industry’s most complete industrial control systems (ICS) cybersecurity platform, this release incorporates new functionality to provide even more “extreme” visibility into ICS networks and help industrial enterprises decrease the risk of a cyberattack. The latest release of Claroty Continuous Threat Detection provides a large number of significant enhancements including: Virtual Zones and OT Network Segmentation – an innovative approach

INN Launches Battery Metals Channel11.12.2018 15:00Pressemelding

The new battery metals channel is designed to educate investors with original content and expert insight on the growing battery metals industry. VANCOUVER, British Columbia, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Investing News Network (INN) announces the launch of its battery metals channel. Responding to the growth and evolution of the battery metals market, this channel will host news, educational content and expert opinions on the lithium, cobalt, graphite, vanadium and manganese market segments. “INN has been a trusted source of information on the lithium, cobalt, graphite, vanadium and manganese markets for nearly a decade, and is excited to bring these sectors together under the battery metals umbrella,” said Nick Smith, CEO and publisher at INN. “Through connections with experts, our leading team of experienced writers creates original, insightful content on battery metals. INN educates investors in the industry by providing information they may never have access to on their own,” S

Galimedix Therapeutics Appoints Industry Veteran, Hermann Russ, M.D., Ph.D., Chief Scientific Officer11.12.2018 14:30Pressemelding

KENSINGTON, Md. and SHORASHIM, Israel, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Galimedix Therapeutics, which is developing new solutions for ophthalmic and neurodegenerative diseases, announced the appointment of Hermann Russ, M.D., Ph.D., as its chief scientific officer, effective December 1, 2018. Dr. Russ invented the use of the company’s lead molecule GAL-101/MRZ-99030 for the treatment of degenerative diseases of the retina, including glaucoma and dry macular degeneration. He is also co-inventor of the so-called “trigger effect” of GAL-101/MRZ-99030 and GAL-102/MRZ 14042, which is a unique reverse prion-like self-propagation mechanism of action important for the company’s eye drop and oral treatment regimens. “We are gratified that Dr. Russ is joining the Galimedix management team, as his knowledge in the field, as well as intimate experience with the compound, have already proven instrumental in the development of our company to date,” commented Andrew Pearlman, Ph.D., CEO of Galimedix

Farmako: Cannabis distributor to become gateway to Europe11.12.2018 10:00Pressemelding

Company is first to apply for a licence in the United Kingdom AAA-Team pushes to become gateway to Europe Company first to apply for distribution licences in UK Support of Canadian LP to obtain EU-GMP Focus on research and development FRANKFURT, Germany, Dec. 11, 2018 (GLOBE NEWSWIRE) -- The Frankfurt-based pharmaceutical company Farmako is a research-based pharmaceutical company that distributes medical cannabis. The company is active in all European markets that have created a legal basis for cannabinoid therapies. It is the first company for medical Cannabis pursue distribution licences in multiple European countries. Fort hat, it will rely on EU-GMP certified suppliers. The German market for medical cannabis is estimated at 19.1 million euros in 2018 and at 200 million Euros by 2019. For 2028, experts expect a market volume for medical cannabis of 7.8 billion euros in Germany, an increase by a factor of 400. The number of patients for cannabinoid therapies in Germany has grown from

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom